Detection of malignant tumors: Whole-body PET with fluorine 18 α-methyl tyrosine versus FDG - Preliminary study

Radiology

Volumn 220, Issue 1, 2001, Pages 54-62

  Inoue, T ^a   Koyama, K ^a   Oriuchi, N ^a   Alyafei, S ^a   Yuan, Z ^a   Suzuki, H ^a   Takeuchi, K ^a   Tomaru, Y ^a   Tomiyoshi, K ^a   Aoki, J ^a   Endo, K ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Fluorine, radioactive; Metabolism; Neoplasms, PET, **.121632, **.12166; Positron emission tomography (PET), comparative studies, **.12163, **.12166, 10.12173; Positron emission tomography (PET), technology, **.12163, **.12166, 10.12173

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; METIROSINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG UPTAKE; EQUIPMENT; FEMALE; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 17744401375     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.220.1.r01jl1654     Document Type: Article

References (30)

1. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors
2. 18F-fluorodeoxyglucose positron-emission tomography (letter)
3. Oncological application of positron emission tomography with fluorine-18 fluorodeoxyglucose
4. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography
5. Feasibility of fluorine-18-fluorophenylalanine for tumor imaging compared with carbon-11-L-methionine
6. 18F]fluorotyrosine, a new PET tracer of protein synthesis
7. 124IMT, and first clinical results
8. 123I]iodo-alpha-methyltyrosine
9. Feasibility of tumor imaging using L-3-[iodine-123]-iodo-α-methyl-tyrosine in extracranial tumors
10. 18F-α-methyltyrosine using a separation and purification system
11. 18F α-methyl tyrosine PET studies in patients with brain tumors
12. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution
13. Accuracy of standardized uptake value (SUV) measured by simultaneous emission and transmission scanning in PET oncology
14. Comparisons of predictive values of binary medical diagnostic tests for paired designs
15. Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging
16. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET
17. Excess muscle FDG uptake in a euglycaemic patient that is corrected by fasting
18. Effect of the duration of fasting on myocardial fluorine-18-fluorodeoxyglucose positron emission tomography images in normal males
19. Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants
20. 123I]iodo-α-methyl tyrosine: Competition with natural L-amino acids
21. 18F)fluoro-α-methyl tyrosine: A potential tumordetecting agent
22. Detecting recurrent or residual lung cancer with FDG-PET
23. 18F]-fluorodeoxyglucose uptake in abdominal abscesses: A PET study
24. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis
25. How amino acids get into cells: Mechanisms, models, menus, and mediators
26. Uptake and distribution of L-3-[I-125] iodo-α-methyl tyrosine in experimental rat tumours: Comparison with blood flow and growth rate
27. Accumulation of radioiodinated tyrosine derivatives in the adrenal medulla and in melanoma
28. Is there a future for clinical fluorine-18 radiopharmaceuticals (excluding FDG)?